Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

David J. Hunter, Sc.D., M.B.,B.S.

Co-Author

This page shows the publications co-authored by David Hunter and Meir Stampfer.
Connection Strength

3.973
  1. Oral contraceptive use and breast cancer: a prospective study of young women. Cancer Epidemiol Biomarkers Prev. 2010 Oct; 19(10):2496-502.
    View in: PubMed
    Score: 0.116
  2. CYP19A1 genetic variation in relation to prostate cancer risk and circulating sex hormone concentrations in men from the Breast and Prostate Cancer Cohort Consortium. Cancer Epidemiol Biomarkers Prev. 2009 Oct; 18(10):2734-44.
    View in: PubMed
    Score: 0.109
  3. A common 8q24 variant in prostate and breast cancer from a large nested case-control study. Cancer Res. 2007 Apr 01; 67(7):2951-6.
    View in: PubMed
    Score: 0.092
  4. p53 Arg72Pro polymorphism and risk of colorectal adenoma and cancer. Int J Cancer. 2006 Oct 15; 119(8):1863-8.
    View in: PubMed
    Score: 0.089
  5. A candidate gene approach to searching for low-penetrance breast and prostate cancer genes. Nat Rev Cancer. 2005 12; 5(12):977-85.
    View in: PubMed
    Score: 0.084
  6. Linkage disequilibrium between the 677C>T and 1298A>C polymorphisms in human methylenetetrahydrofolate reductase gene and their contributions to risk of colorectal cancer. Pharmacogenetics. 2002 Jun; 12(4):339-42.
    View in: PubMed
    Score: 0.066
  7. Alcohol dehydrogenase 3 genotype is not predictive for risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2001 Dec; 10(12):1303-4.
    View in: PubMed
    Score: 0.063
  8. The relationship between a polymorphism in CYP17 with plasma hormone levels and prostate cancer. Cancer Epidemiol Biomarkers Prev. 2001 Jul; 10(7):743-8.
    View in: PubMed
    Score: 0.062
  9. Genetic variation in alcohol dehydrogenase and the beneficial effect of moderate alcohol consumption on myocardial infarction. N Engl J Med. 2001 Feb 22; 344(8):549-55.
    View in: PubMed
    Score: 0.060
  10. Influence of a methionine synthase (D919G) polymorphism on plasma homocysteine and folate levels and relation to risk of myocardial infarction. Atherosclerosis. 2001 Feb 15; 154(3):667-72.
    View in: PubMed
    Score: 0.060
  11. Epidemiology of interstitial cystitis: a population based study. J Urol. 1999 Feb; 161(2):549-52.
    View in: PubMed
    Score: 0.052
  12. Glutathione S-transferase GSTM1 and GSTT1 polymorphisms and colorectal cancer risk: a prospective study. Cancer Epidemiol Biomarkers Prev. 1998 Nov; 7(11):1001-5.
    View in: PubMed
    Score: 0.051
  13. Risk of uterine leiomyomata among premenopausal women in relation to body size and cigarette smoking. Epidemiology. 1998 Sep; 9(5):511-7.
    View in: PubMed
    Score: 0.051
  14. A prospective study of reproductive factors and oral contraceptive use in relation to the risk of uterine leiomyomata. Fertil Steril. 1998 Sep; 70(3):432-9.
    View in: PubMed
    Score: 0.051
  15. A prospective study of N-acetyltransferase genotype, red meat intake, and risk of colorectal cancer. Cancer Res. 1998 Aug 01; 58(15):3307-11.
    View in: PubMed
    Score: 0.050
  16. A common mutation in the methylenetetrahydrofolate reductase gene and risk of coronary heart disease: results among U.S. men. J Am Coll Cardiol. 1998 Aug; 32(2):353-9.
    View in: PubMed
    Score: 0.050
  17. Vitamin D receptor polymorphisms, circulating vitamin D metabolites, and risk of prostate cancer in United States physicians. Cancer Epidemiol Biomarkers Prev. 1998 May; 7(5):385-90.
    View in: PubMed
    Score: 0.049
  18. Reproducibility of oral contraceptive histories and validity of hormone composition reported in a cohort of US women. Contraception. 1997 Dec; 56(6):373-8.
    View in: PubMed
    Score: 0.048
  19. Measurement of retinoids and carotenoids in breast adipose tissue and a comparison of concentrations in breast cancer cases and control subjects. Am J Clin Nutr. 1997 Sep; 66(3):626-32.
    View in: PubMed
    Score: 0.047
  20. Glutathione S-transferase class mu deletion polymorphism and breast cancer: results from prevalent versus incident cases. Cancer Epidemiol Biomarkers Prev. 1997 Jul; 6(7):511-5.
    View in: PubMed
    Score: 0.047
  21. Genomic analyses identify hundreds of variants associated with age at menarche and support a role for puberty timing in cancer risk. Nat Genet. 2017 Jun; 49(6):834-841.
    View in: PubMed
    Score: 0.046
  22. A comprehensive survey of genetic variation in 20,691 subjects from four large cohorts. PLoS One. 2017; 12(3):e0173997.
    View in: PubMed
    Score: 0.046
  23. Interactions Between Genome-Wide Significant Genetic Variants and Circulating Concentrations of 25-Hydroxyvitamin D in Relation to Prostate Cancer Risk in the National Cancer Institute BPC3. Am J Epidemiol. 2017 03 15; 185(6):452-464.
    View in: PubMed
    Score: 0.046
  24. A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer. Cancer Res. 1996 Nov 01; 56(21):4862-4.
    View in: PubMed
    Score: 0.045
  25. Toenail trace element levels and breast cancer: a prospective study. Am J Epidemiol. 1996 Oct 01; 144(7):653-60.
    View in: PubMed
    Score: 0.044
  26. PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS. J Med Genet. 2016 12; 53(12):800-811.
    View in: PubMed
    Score: 0.044
  27. Prospective study of oral contraceptives and hypertension among women in the United States. Circulation. 1996 Aug 01; 94(3):483-9.
    View in: PubMed
    Score: 0.044
  28. Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations. Cancer Res. 2016 09 01; 76(17):5103-14.
    View in: PubMed
    Score: 0.043
  29. Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for Thirteen Cancer Types. J Natl Cancer Inst. 2015 Dec; 107(12):djv279.
    View in: PubMed
    Score: 0.041
  30. Genome-wide association study of prostate cancer-specific survival. Cancer Epidemiol Biomarkers Prev. 2015 Nov; 24(11):1796-800.
    View in: PubMed
    Score: 0.041
  31. ABO blood group alleles and prostate cancer risk: Results from the breast and prostate cancer cohort consortium (BPC3). Prostate. 2015 Nov; 75(15):1677-81.
    View in: PubMed
    Score: 0.041
  32. Integration of multiethnic fine-mapping and genomic annotation to prioritize candidate functional SNPs at prostate cancer susceptibility regions. Hum Mol Genet. 2015 Oct 01; 24(19):5603-18.
    View in: PubMed
    Score: 0.041
  33. Prospective study of toenail selenium levels and cancer among women. J Natl Cancer Inst. 1995 Apr 05; 87(7):497-505.
    View in: PubMed
    Score: 0.040
  34. A prospective study of permanent hair dye use and hematopoietic cancer. J Natl Cancer Inst. 1994 Oct 05; 86(19):1466-70.
    View in: PubMed
    Score: 0.039
  35. A genome-wide pleiotropy scan for prostate cancer risk. Eur Urol. 2015 Apr; 67(4):649-57.
    View in: PubMed
    Score: 0.039
  36. A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer. Nat Genet. 2014 Oct; 46(10):1103-9.
    View in: PubMed
    Score: 0.038
  37. A prospective study of symptomatic gallstones in women: relation with oral contraceptives and other risk factors. Obstet Gynecol. 1994 Aug; 84(2):207-14.
    View in: PubMed
    Score: 0.038
  38. Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche. Nature. 2014 Oct 02; 514(7520):92-97.
    View in: PubMed
    Score: 0.038
  39. Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33. Hum Mol Genet. 2014 Dec 15; 23(24):6616-33.
    View in: PubMed
    Score: 0.038
  40. Toenail trace element levels as biomarkers: reproducibility over a 6-year period. Cancer Epidemiol Biomarkers Prev. 1993 Sep-Oct; 2(5):493-7.
    View in: PubMed
    Score: 0.036
  41. A prospective study of the intake of vitamins C, E, and A and the risk of breast cancer. N Engl J Med. 1993 Jul 22; 329(4):234-40.
    View in: PubMed
    Score: 0.036
  42. Mannose-binding lectin 2 gene and risk of adult glioma. PLoS One. 2013; 8(4):e61117.
    View in: PubMed
    Score: 0.035
  43. Single-nucleotide polymorphisms of allergy-related genes and risk of adult glioma. J Neurooncol. 2013 Jun; 113(2):229-38.
    View in: PubMed
    Score: 0.035
  44. Genetic variation in the vitamin d pathway in relation to risk of prostate cancer--results from the breast and prostate cancer cohort consortium. Cancer Epidemiol Biomarkers Prev. 2013 Apr; 22(4):688-96.
    View in: PubMed
    Score: 0.034
  45. Association of type 2 diabetes susceptibility variants with advanced prostate cancer risk in the Breast and Prostate Cancer Cohort Consortium. Am J Epidemiol. 2012 Dec 15; 176(12):1121-9.
    View in: PubMed
    Score: 0.034
  46. A quantitative assessment of oral contraceptive use and risk of ovarian cancer. Obstet Gynecol. 1992 Oct; 80(4):708-14.
    View in: PubMed
    Score: 0.034
  47. Diet and risk of basal cell carcinoma of the skin in a prospective cohort of women. Ann Epidemiol. 1992 May; 2(3):231-9.
    View in: PubMed
    Score: 0.033
  48. Interactions between genome-wide significant genetic variants and circulating concentrations of insulin-like growth factor 1, sex hormones, and binding proteins in relation to prostate cancer risk in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. Am J Epidemiol. 2012 May 01; 175(9):926-35.
    View in: PubMed
    Score: 0.032
  49. Plasma folate, methylenetetrahydrofolate reductase (MTHFR), and colorectal cancer risk in three large nested case-control studies. Cancer Causes Control. 2012 Apr; 23(4):537-45.
    View in: PubMed
    Score: 0.032
  50. Comparison of measures of fatty acid intake by subcutaneous fat aspirate, food frequency questionnaire, and diet records in a free-living population of US men. Am J Epidemiol. 1992 Feb 15; 135(4):418-27.
    View in: PubMed
    Score: 0.032
  51. Y chromosome haplogroups and prostate cancer in populations of European and Ashkenazi Jewish ancestry. Hum Genet. 2012 Jul; 131(7):1173-85.
    View in: PubMed
    Score: 0.032
  52. Common genetic variants in prostate cancer risk prediction--results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3). Cancer Epidemiol Biomarkers Prev. 2012 Mar; 21(3):437-44.
    View in: PubMed
    Score: 0.032
  53. Replication of five prostate cancer loci identified in an Asian population--results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3). Cancer Epidemiol Biomarkers Prev. 2012 Jan; 21(1):212-6.
    View in: PubMed
    Score: 0.032
  54. Prediagnostic plasma IgE levels and risk of adult glioma in four prospective cohort studies. J Natl Cancer Inst. 2011 Nov 02; 103(21):1588-95.
    View in: PubMed
    Score: 0.031
  55. Genome-wide association study identifies new prostate cancer susceptibility loci. Hum Mol Genet. 2011 Oct 01; 20(19):3867-75.
    View in: PubMed
    Score: 0.031
  56. Association of KLK3 (PSA) genetic variants with prostate cancer risk and PSA levels. Carcinogenesis. 2011 Jun; 32(6):853-9.
    View in: PubMed
    Score: 0.030
  57. Characterizing associations and SNP-environment interactions for GWAS-identified prostate cancer risk markers--results from BPC3. PLoS One. 2011 Feb 24; 6(2):e17142.
    View in: PubMed
    Score: 0.030
  58. Analysis of the 10q11 cancer risk locus implicates MSMB and NCOA4 in human prostate tumorigenesis. PLoS Genet. 2010 Nov 11; 6(11):e1001204.
    View in: PubMed
    Score: 0.029
  59. Genome-wide association study of prostate cancer mortality. Cancer Epidemiol Biomarkers Prev. 2010 Nov; 19(11):2869-76.
    View in: PubMed
    Score: 0.029
  60. Risk factors for basal cell carcinoma in a prospective cohort of women. Ann Epidemiol. 1990 Oct; 1(1):13-23.
    View in: PubMed
    Score: 0.029
  61. A prospective study of selenium status and breast cancer risk. JAMA. 1990 Sep 05; 264(9):1128-31.
    View in: PubMed
    Score: 0.029
  62. Intakes of vitamins A, C, and E and use of multiple vitamin supplements and risk of colon cancer: a pooled analysis of prospective cohort studies. Cancer Causes Control. 2010 Nov; 21(11):1745-57.
    View in: PubMed
    Score: 0.029
  63. Eighteen insulin-like growth factor pathway genes, circulating levels of IGF-I and its binding protein, and risk of prostate and breast cancer. Cancer Epidemiol Biomarkers Prev. 2010 Nov; 19(11):2877-87.
    View in: PubMed
    Score: 0.029
  64. Predictors of selenium concentration in human toenails. Am J Epidemiol. 1990 Jul; 132(1):114-22.
    View in: PubMed
    Score: 0.029
  65. A large study of androgen receptor germline variants and their relation to sex hormone levels and prostate cancer risk. Results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. J Clin Endocrinol Metab. 2010 Sep; 95(9):E121-7.
    View in: PubMed
    Score: 0.029
  66. A comprehensive analysis of common IGF1, IGFBP1 and IGFBP3 genetic variation with prospective IGF-I and IGFBP-3 blood levels and prostate cancer risk among Caucasians. Hum Mol Genet. 2010 Aug 01; 19(15):3089-101.
    View in: PubMed
    Score: 0.029
  67. A large prospective study of SEP15 genetic variation, interaction with plasma selenium levels, and prostate cancer risk and survival. Cancer Prev Res (Phila). 2010 May; 3(5):604-10.
    View in: PubMed
    Score: 0.028
  68. PTGS2 and IL6 genetic variation and risk of breast and prostate cancer: results from the Breast and Prostate Cancer Cohort Consortium (BPC3). Carcinogenesis. 2010 Mar; 31(3):455-61.
    View in: PubMed
    Score: 0.028
  69. Quantitative trait loci predicting circulating sex steroid hormones in men from the NCI-Breast and Prostate Cancer Cohort Consortium (BPC3). Hum Mol Genet. 2009 Oct 01; 18(19):3749-57.
    View in: PubMed
    Score: 0.027
  70. Fine mapping and functional analysis of a common variant in MSMB on chromosome 10q11.2 associated with prostate cancer susceptibility. Proc Natl Acad Sci U S A. 2009 May 12; 106(19):7933-8.
    View in: PubMed
    Score: 0.026
  71. Evaluation of 8q24 and 17q risk loci and prostate cancer mortality. Clin Cancer Res. 2009 May 01; 15(9):3223-30.
    View in: PubMed
    Score: 0.026
  72. Variation in KLK genes, prostate-specific antigen and risk of prostate cancer. Nat Genet. 2008 Sep; 40(9):1032-4; author reply 1035-6.
    View in: PubMed
    Score: 0.025
  73. Variability in portion sizes of commonly consumed foods among a population of women in the United States. Am J Epidemiol. 1988 Jun; 127(6):1240-9.
    View in: PubMed
    Score: 0.025
  74. Brian MacMahon (1923-2007): founder of modern epidemiology. Cancer Causes Control. 2008 May; 19(4):329-37.
    View in: PubMed
    Score: 0.025
  75. CYP17 genetic variation and risk of breast and prostate cancer from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3). Cancer Epidemiol Biomarkers Prev. 2007 Nov; 16(11):2237-46.
    View in: PubMed
    Score: 0.024
  76. Sequence variants of estrogen receptor beta and risk of prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. Cancer Epidemiol Biomarkers Prev. 2007 Oct; 16(10):1973-81.
    View in: PubMed
    Score: 0.024
  77. A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer. PLoS Med. 2007 Mar; 4(3):e103.
    View in: PubMed
    Score: 0.023
  78. Red meat intake and risk of breast cancer among premenopausal women. Arch Intern Med. 2006 Nov 13; 166(20):2253-9.
    View in: PubMed
    Score: 0.022
  79. Dietary fat and risk of postmenopausal breast cancer in a 20-year follow-up. Am J Epidemiol. 2006 Nov 15; 164(10):990-7.
    View in: PubMed
    Score: 0.022
  80. Genetic variation in the HSD17B1 gene and risk of prostate cancer. PLoS Genet. 2005 Nov; 1(5):e68.
    View in: PubMed
    Score: 0.021
  81. Alcohol intake and methylenetetrahydrofolate reductase polymorphism modify the relation of folate intake to plasma homocysteine. Am J Clin Nutr. 2005 Jul; 82(1):155-62.
    View in: PubMed
    Score: 0.020
  82. Fiber intake and incidence of colorectal cancer among 76,947 women and 47,279 men. Cancer Epidemiol Biomarkers Prev. 2005 Apr; 14(4):842-9.
    View in: PubMed
    Score: 0.020
  83. Alcohol consumption and high-density lipoprotein levels: the effect of ADH1C genotype, gender and menopausal status. Atherosclerosis. 2005 Oct; 182(2):293-300.
    View in: PubMed
    Score: 0.020
  84. Polymorphism in the thymidylate synthase promoter enhancer region modifies the risk and survival of colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2003 Oct; 12(10):958-62.
    View in: PubMed
    Score: 0.018
  85. Premenopausal fat intake and risk of breast cancer. J Natl Cancer Inst. 2003 Jul 16; 95(14):1079-85.
    View in: PubMed
    Score: 0.018
  86. Major dietary patterns and the risk of colorectal cancer in women. Arch Intern Med. 2003 Feb 10; 163(3):309-14.
    View in: PubMed
    Score: 0.017
  87. Diet quality and major chronic disease risk in men and women: moving toward improved dietary guidance. Am J Clin Nutr. 2002 Dec; 76(6):1261-71.
    View in: PubMed
    Score: 0.017
  88. Use of postmenopausal hormones, alcohol, and risk for invasive breast cancer. Ann Intern Med. 2002 Nov 19; 137(10):798-804.
    View in: PubMed
    Score: 0.017
  89. Dietary fat intake and ovarian cancer in a cohort of US women. Am J Epidemiol. 2002 Jul 01; 156(1):22-31.
    View in: PubMed
    Score: 0.017
  90. Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. JAMA. 2002 Apr 10; 287(14):1815-21.
    View in: PubMed
    Score: 0.016
  91. Active and passive smoking in breast cancer: prospective results from the Nurses' Health Study. Epidemiology. 2002 Mar; 13(2):138-45.
    View in: PubMed
    Score: 0.016
  92. The influence of folate and multivitamin use on the familial risk of colon cancer in women. Cancer Epidemiol Biomarkers Prev. 2002 Mar; 11(3):227-34.
    View in: PubMed
    Score: 0.016
  93. Physical activity and mortality: a prospective study among women. Am J Public Health. 2001 Apr; 91(4):578-83.
    View in: PubMed
    Score: 0.015
  94. Adherence to the Dietary Guidelines for Americans and risk of major chronic disease in women. Am J Clin Nutr. 2000 Nov; 72(5):1214-22.
    View in: PubMed
    Score: 0.015
  95. A prospective study of cytochrome P450 1A1 polymorphisms and colorectal cancer risk in men. Cancer Epidemiol Biomarkers Prev. 2000 Aug; 9(8):855-6.
    View in: PubMed
    Score: 0.014
  96. Diet and basal cell carcinoma of the skin in a prospective cohort of men. Am J Clin Nutr. 2000 Jan; 71(1):135-41.
    View in: PubMed
    Score: 0.014
  97. Oral contraceptive use and risk of melanoma in premenopausal women. Br J Cancer. 1999 Nov; 81(5):918-23.
    View in: PubMed
    Score: 0.014
  98. Alcohol consumption in relation to breast cancer risk in a cohort of United States women 25-42 years of age. Cancer Epidemiol Biomarkers Prev. 1999 Nov; 8(11):1017-21.
    View in: PubMed
    Score: 0.014
  99. High body mass index and hypercholesterolemia: risk of hypertensive disorders of pregnancy. Obstet Gynecol. 1999 Oct; 94(4):543-50.
    View in: PubMed
    Score: 0.014
  100. Dietary factors and the survival of women with breast carcinoma. Cancer. 1999 Sep 01; 86(5):826-35.
    View in: PubMed
    Score: 0.014
  101. A polymorphism of the methionine synthase gene: association with plasma folate, vitamin B12, homocyst(e)ine, and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev. 1999 Sep; 8(9):825-9.
    View in: PubMed
    Score: 0.014
  102. Association of dietary intake of fat and fatty acids with risk of breast cancer. JAMA. 1999 Mar 10; 281(10):914-20.
    View in: PubMed
    Score: 0.013
  103. Dietary fiber and the risk of colorectal cancer and adenoma in women. N Engl J Med. 1999 Jan 21; 340(3):169-76.
    View in: PubMed
    Score: 0.013
  104. Multivitamin use, folate, and colon cancer in women in the Nurses' Health Study. Ann Intern Med. 1998 Oct 01; 129(7):517-24.
    View in: PubMed
    Score: 0.013
  105. Menstrual cycle characteristics and history of ovulatory infertility in relation to breast cancer risk in a large cohort of US women. Am J Epidemiol. 1998 Apr 01; 147(7):636-43.
    View in: PubMed
    Score: 0.012
  106. Dual effects of weight and weight gain on breast cancer risk. JAMA. 1997 Nov 05; 278(17):1407-11.
    View in: PubMed
    Score: 0.012
  107. A prospective study of pregravid determinants of gestational diabetes mellitus. JAMA. 1997 Oct 01; 278(13):1078-83.
    View in: PubMed
    Score: 0.012
  108. Oral contraceptives and ovulatory causes of delayed fertility. Am J Epidemiol. 1997 Aug 01; 146(3):258-65.
    View in: PubMed
    Score: 0.012
  109. Postmenopausal hormone therapy and mortality. N Engl J Med. 1997 Jun 19; 336(25):1769-75.
    View in: PubMed
    Score: 0.012
  110. Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res. 1997 Mar 15; 57(6):1098-102.
    View in: PubMed
    Score: 0.011
  111. A prospective study of oral contraceptives and NIDDM among U.S. women. Diabetes Care. 1997 Mar; 20(3):330-5.
    View in: PubMed
    Score: 0.011
  112. A prospective study of oral contraceptive use and risk of breast cancer (Nurses' Health Study, United States). Cancer Causes Control. 1997 Jan; 8(1):65-72.
    View in: PubMed
    Score: 0.011
  113. A prospective study of cigarette smoking and the risk of pancreatic cancer. Arch Intern Med. 1996 Oct 28; 156(19):2255-60.
    View in: PubMed
    Score: 0.011
  114. Calcium, vitamin D, and the occurrence of colorectal cancer among women. J Natl Cancer Inst. 1996 Oct 02; 88(19):1375-82.
    View in: PubMed
    Score: 0.011
  115. Self-reported birthweight and history of having been breastfed among younger women: an assessment of validity. Int J Epidemiol. 1996 Feb; 25(1):122-7.
    View in: PubMed
    Score: 0.011
  116. Variability in diagnostic evaluation and criteria for gestational diabetes. Diabetes Care. 1996 Jan; 19(1):12-6.
    View in: PubMed
    Score: 0.011
  117. Body weight and mortality among women. N Engl J Med. 1995 Sep 14; 333(11):677-85.
    View in: PubMed
    Score: 0.010
  118. Aspirin and the risk of colorectal cancer in women. N Engl J Med. 1995 Sep 07; 333(10):609-14.
    View in: PubMed
    Score: 0.010
  119. Alcohol, height, and adiposity in relation to estrogen and prolactin levels in postmenopausal women. J Natl Cancer Inst. 1995 Sep 06; 87(17):1297-302.
    View in: PubMed
    Score: 0.010
  120. The validity of recalled weight among younger women. Int J Obes Relat Metab Disord. 1995 Aug; 19(8):570-2.
    View in: PubMed
    Score: 0.010
  121. A prospective study of reproductive factors and risk of epithelial ovarian cancer. Cancer. 1995 Jul 15; 76(2):284-90.
    View in: PubMed
    Score: 0.010
  122. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med. 1995 Jun 15; 332(24):1589-93.
    View in: PubMed
    Score: 0.010
  123. Alcohol consumption and mortality among women. N Engl J Med. 1995 May 11; 332(19):1245-50.
    View in: PubMed
    Score: 0.010
  124. Reproductive factors and family history of breast cancer in relation to plasma estrogen and prolactin levels in postmenopausal women in the Nurses' Health Study (United States). Cancer Causes Control. 1995 May; 6(3):217-24.
    View in: PubMed
    Score: 0.010
  125. Childhood socioeconomic status and risk of cardiovascular disease in middle aged US women: a prospective study. J Epidemiol Community Health. 1995 Feb; 49(1):10-5.
    View in: PubMed
    Score: 0.010
  126. Reproducibility and validity of a self-administered physical activity questionnaire. Int J Epidemiol. 1994 Oct; 23(5):991-9.
    View in: PubMed
    Score: 0.010
  127. Adolescent body mass index and infertility caused by ovulatory disorder. Am J Obstet Gynecol. 1994 Jul; 171(1):171-7.
    View in: PubMed
    Score: 0.009
  128. A prospective study of cigarette smoking and risk of colorectal adenoma and colorectal cancer in U.S. women. J Natl Cancer Inst. 1994 Feb 02; 86(3):192-9.
    View in: PubMed
    Score: 0.009
  129. Tubal ligation, hysterectomy, and risk of ovarian cancer. A prospective study. JAMA. 1993 Dec 15; 270(23):2813-8.
    View in: PubMed
    Score: 0.009
  130. Smoking cessation in relation to total mortality rates in women. A prospective cohort study. Ann Intern Med. 1993 Nov 15; 119(10):992-1000.
    View in: PubMed
    Score: 0.009
  131. Family history, age, and risk of breast cancer. Prospective data from the Nurses' Health Study. JAMA. 1993 Jul 21; 270(3):338-43.
    View in: PubMed
    Score: 0.009
  132. Dietary fat and fiber in relation to risk of breast cancer. An 8-year follow-up. JAMA. 1992 Oct 21; 268(15):2037-44.
    View in: PubMed
    Score: 0.008
  133. Type of postmenopausal hormone use and risk of breast cancer: 12-year follow-up from the Nurses' Health Study. Cancer Causes Control. 1992 Sep; 3(5):433-9.
    View in: PubMed
    Score: 0.008
  134. Food-based validation of a dietary questionnaire: the effects of week-to-week variation in food consumption. Int J Epidemiol. 1989 Dec; 18(4):858-67.
    View in: PubMed
    Score: 0.007
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.